Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx2 RabG Rabies Vaccine Study in Tanzania
NCT04270838Phase 2Active, not recruiting
- Sponsor
- University of Oxford
- Start
- Feb 2022
- Primary completion
- Sep 2028
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ChAdOx2 RabG in rabies, sponsored by University of Oxford. Started Feb 2022; status: active, not recruiting.
02
Drugs
ChAdOx2 RabG
03
Conditions
rabies
Beyond the preview
Go deeper on NCT04270838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04270838.